Zimmer Biomet Acquires 3D Hip Imaging Startup Clinical Graphics
By Jof Enriquez,
Follow me on Twitter @jofenriq
Zimmer Biomet has announced the acquisition of Clinical Graphics, a Netherlands-based startup with a pioneering 3D interactive range-of-motion simulation platform to help orthopedic surgeons and radiologists plan treatments for hip problems, for an undisclosed amount.
Clinical Graphics' platform converts X-ray, CT, and MRI scans into 3D motion simulation "Move Forward" reports of patients' anatomy to help physicians diagnose conditions such as hip impingement, a condition in which the bones of the ball-and-socket joint are not shaped normally, which can limit motion and cause pain; and dysplasia, a misalignment of the joint, according to XConomy. Clinical Graphics also conducts research on other joints, for instance, on anterior shoulder instability.
Zimmer Biomet said it will integrate Clinical Graphics' 3D imaging platform into its hip preservation portfolio.
"3D imaging represents the next generation of treating joint pain, and we're excited to team up with Clinical Graphics and integrate our technologies to further enhance the clinical utility of our market leading hip portfolio," said Dan Williamson, Group President, Joint Reconstruction for Zimmer Biomet, in a news release.
Clinical Graphics started as a spin-off from Delft University of Technology in 2010, and is based in The Netherlands at technology incubator Yes!Delft.
"Zimmer Biomet is a well-respected leader in musculoskeletal healthcare, and an ideal parent company to usher our breakthrough technologies into mainstream clinical practice as the standard of care for managing joint disease," said Peter Krekel, Managing Director of Clinical Graphics.
The purchase of Clinical Graphics is the latest in a string of bolt-on acquisitions made this year by Zimmer Biomet. Last month, it picked up CD Diagnostics, a fully-integrated, Delaware-based diagnostics company focused on developing immunoassays and biomarker testing. That followed deals to acquire two French companies: MedTech SA to join the surgical robotics market in July, and the $1-billion deal for LDR to help position Zimmer Biomet as market leader in the $10B global spine business.
One year after merging, Zimmer Biomet said full integration has been achieved and the combined company now is eyeing more M&A opportunities.
The company also launched recently its value-based suite of clinical services called Signature Solutions to assist hospitals cut costs and achieve outcomes-based reimbursement targets.